Your browser doesn't support javascript.
loading
Evaluation of Loop-Mediated Isothermal Amplification Assay in Diagnosing Tuberculous Meningitis.
Chauhan, Vishal S; Jorwal, Pankaj; Singh, Binit K; Nischal, Neeraj; Soneja, Manish; Vyas, Surabhi; Vishnu, Venugopalan Y; Sethi, Prayas; Ranjan, Piyush; Wig, Naveet.
Afiliación
  • Chauhan VS; Medicine, All India Institute of Medical Sciences, New Delhi, IND.
  • Jorwal P; Medicine, All India Institute of Medical Sciences, New Delhi, IND.
  • Singh BK; Medicine, All India Institute of Medical Sciences, New Delhi, IND.
  • Nischal N; Medicine, All India Institute of Medical Sciences, New Delhi, IND.
  • Soneja M; Medicine, All India Institute of Medical Sciences, New Delhi, IND.
  • Vyas S; Radiodiagnosis, All India Institute of Medical Sciences, New Delhi, IND.
  • Vishnu VY; Neurology, All India Institute of Medical Sciences, New Delhi, IND.
  • Sethi P; Medicine, All India Institute of Medical Sciences, New Delhi, IND.
  • Ranjan P; Medicine, All India Institute of Medical Sciences, New Delhi, IND.
  • Wig N; Medicine, All India Institute of Medical Sciences, New Delhi, IND.
Cureus ; 16(4): e57490, 2024 Apr.
Article en En | MEDLINE | ID: mdl-38707063
ABSTRACT

BACKGROUND:

Resource-limited settings like India need a simple, quick, and temperature-independent point-of-care diagnostic test that can diagnose tuberculous meningitis (TBM) at the earliest.

METHODS:

A prospective study was carried out at a tertiary care center in North India wherein 50 subjects suspected of TBM were recruited and followed up for six months between January 2019 and December 2020. The aim was to evaluate the performance of loop-mediated isothermal amplification (TB-LAMP) in diagnosing TBM as compared to a composite reference standard (CRS), mycobacteria growth indicator tube 960 (MGIT 960) culture, and GeneXpert®.

RESULTS:

Out of 50 patients, 32 were TBM cases (64%), and 18 were non-TBM cases (36%). The sensitivity of TB-LAMP and GeneXpert® for TBM diagnosis against CRS was 53% (17/32) for both, and the specificity was 78% (14/18) and 89% (16/18), respectively. On comparing TB-LAMP against GeneXpert® for TBM diagnosis, the two methods had almost perfect agreement (Cohen's kappa=0.83) with statistical significance (p<0.001).

CONCLUSION:

The performance of TB-LAMP assay is comparable to GeneXpert® in diagnosing TBM, and it may be used as a substitute for CSF GeneXpert® in resource-limited settings.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos